Literature DB >> 4595579

"Alpha chain disease" protein def: internal deletion of a human immunoglobulin A1 heavy chain.

C Wolfenstein-Todel, E Mihaesco, B Frangione.   

Abstract

Protein Def is a human alpha chain disease protein related to alpha1 immunoglobulin heavy chain. The molecular weight of the polypeptide portion of the monomeric molecule is 29,300, which is a little greater than half of a normal alpha1 chain. The NH(2)-terminal of the polypeptide is heterogenous and, after a short segment corresponding to the variable region, displays a gap which comprises the C(H)1 constant domain. Normal synthesis resumes at a valine residue in the hinge region just before a segment which contains a partially duplicated fragment and the interheavy disulfide bonds. From there on, the molecule is apparently normal. Protein Def is therefore synthesized as an internally deleted alpha1 heavy chain, followed by postsynthetic amino-terminal proteolysis. It is postulated that codon(s) specifying valine at the hinge region may be a recognition site for reinitiating synthesis after internal gaps equivalent to position 216 in gamma chain disease proteins.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4595579      PMCID: PMC388140          DOI: 10.1073/pnas.71.3.974

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Heavy chain disease of the gamma (gamma M) type: report of the first case.

Authors:  F A Forte; F Prelli; W J Yount; L M Jerry; S Kochwa; E C Franklin; H G Kunkel
Journal:  Blood       Date:  1970-08       Impact factor: 22.113

2.  Alpha-chain disease: a new immunoglobulin abnormality.

Authors:  M Seligmann; F Danon; D Hurez; E Mihaesco; J L Preud'homme
Journal:  Science       Date:  1968-12-20       Impact factor: 47.728

3.  IgA abnormalities in abdominal lymphoma (alpha-chain disease).

Authors:  M Seligmann; J C Rambaud
Journal:  Isr J Med Sci       Date:  1969 Mar-Apr

4.  Partial deletion in the heavy chain disease protein ZUC.

Authors:  B Frangione; C Milstein
Journal:  Nature       Date:  1969-11-08       Impact factor: 49.962

5.  Molecular heterogeneity in the amino-terminal region of alkaline phosphatase.

Authors:  S Natori; A Garen
Journal:  J Mol Biol       Date:  1970-05-14       Impact factor: 5.469

6.  Clinico-pathological study of a patient with "Mediterranean" type of abdominal lymphoma and a new type of IgA abnormality ("alpha chain disease").

Authors:  J C Rambaud; C Bognel; A Prost; J J Bernier; Y Le Quintrec; A Lambling; F Danon; D Hurez; M Seligmann
Journal:  Digestion       Date:  1968       Impact factor: 3.216

7.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

8.  Immunochemical studies in four cases of alpha chain disease.

Authors:  M Seligmann; E Mihaesco; D Hurez; C Mihaesco; J L Preud'homme; J C Rambaud
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

9.  Electrophoretic mobilities of peptides on paper and their use in the determination of amide groups.

Authors:  R E Offord
Journal:  Nature       Date:  1966-08-06       Impact factor: 49.962

10.  Location of disulphide bridges by diagonal paper electrophoresis. The disulphide bridges of bovine chymotrypsinogen A.

Authors:  J R Brown; B S Hartley
Journal:  Biochem J       Date:  1966-10       Impact factor: 3.857

View more
  6 in total

Review 1.  Alpha-chain disease.

Authors:  M Seligmann
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

2.  Alpha chain disease: immunoglobulin abnormalities, pathogenesis and current concepts.

Authors:  M Seligmann
Journal:  Br J Cancer Suppl       Date:  1975-03

3.  Alpha-chain disease and related small-intestinal lymphoma: a memorandum.

Authors: 
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

4.  Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease.

Authors:  A G Plaut; R Wistar; J D Capra
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

5.  An unfolded CH1 domain controls the assembly and secretion of IgG antibodies.

Authors:  Matthias J Feige; Sandra Groscurth; Moritz Marcinowski; Yuichiro Shimizu; Horst Kessler; Linda M Hendershot; Johannes Buchner
Journal:  Mol Cell       Date:  2009-06-12       Impact factor: 17.970

6.  Sequence composition predicts immunoglobulin superfamily members that could share the intrinsically disordered properties of antibody CH1 domains.

Authors:  Max Hebditch; Robin Curtis; Jim Warwicker
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.